1. and , The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol (1988), 158:892–8.
2. , Why Mothers Die 2000–2002. Report on confidential enquiries into maternal deaths in the United Kingdom (London: Royal College of Obstetricians and Gynaecologists, 2004).
3. , , and , Prediction of preeclampsia: can it be achieved?Obstet Gynecol Surv (2004), 59:464–82; quiz 485.
4. , 5th Annual Report. (London: Maternal and Child Health Research Consortium, 1998).
5. , , , and , Perinatal predictors of growth at six months in small for gestational age babies. Early Hum Dev (1999), 56:205–16.
6. , , , , , and , Fetal nutrition and cardiovascular disease in adult life. Lancet (1993), 341:938–41.
7. and , Placental debris, oxidative stress and pre-eclampsia. Placenta (2000), 21:597–602.
8. and , Is oxidative stress the link in the two-stage model of pre-eclampsia?Lancet (1999), 354:788–9.
9. and , Antioxidant therapy to prevent preeclampsia. Semin Nephrol (2004), 24:557–64.
10. , , , , and , et al., Functional food science and defence against reactive oxidative species. Br J Nutr (1998), 80(Suppl 1):S77–112.
11. , , , and , Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev (2005), 4:CD004227.
12. , , , , , , et al., Effect of antioxidants on the occurrence of preeclampsia in women at increased risk: a randomised trial. Lancet (1999), 354:810–6.
13. , , , , and , and vitamin E in pregnant women at risk for preeclampsia (VIP trial): randomised placebo-controlled trial. Lancet (2006), 367:1145–54.
14. , , , , and , and E and the risks of preeclampsia and perinatal complications. N Engl J Med (2006), 354:1796–806.
15. , , , , , , et al., Vitamin E supplementation in preeclampsia. Gynecol Obstet Investig (1994), 37:246–9.
16. , , and , Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial. BJOG (1997), 104:689–96.
17. 3rd, , , , , and , Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med (2005), 142:37–46.
18. , , , , , , and , High maternal vitamin E intake by diet or supplements is associated with congenital heart defects in the offspring. BJOG (2009), 116:416–23.
19. , , , , and , A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of pre-eclampsia. Eur J Clin Investig (1994), 24:76–8.
20. , , , , and , Effects of nitroglycerin on the uterine and umbilical circulation in severe preeclampsia. Obstet Gynecol (1995), 86:600–4.
21. , , , , and , Impact of the L-arginine/nitric oxide system in pregnancy. Obstet Gynecol Surv (1995), 50:851–8.
22. , , , , and , L-arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release. J Soc Gynecol Investig (1999), 6:202–7.
23. , , , , and , L-arginine supplementation in patients with gestational hypertension: a pilot study. Hypertens Pregn (2007), 26:121–30.
24. , Dietary supplementation with L-arginine in women with preeclampsia. Acta Obstet Gynecol Scand (2004), 83:871; author reply 872.
25. , , and , Dietary calcium supplementation for prevention of preeclampsia and related problems: a systematic review and commentary. BJOG, 114:933–43.
26. , , and (1994) [The effects of Salvia miltiorrhizae Bge and Ligustrazine on thromboxane A2 and prostacyclin in pregnancy induced hypertension]. Zhonghua Fu Chan Ke Za Zhi (2007), 29:648–50, 697.
27. , , and , Chinese herbal medicine for the treatment of pre-eclampsia. Cochrane Database Syst Rev (2006), (2):CD005126.
28. and , Fish-oil and pre-eclampsia. BJOG (1990), 97:1077–9.
29. , , , , , and , Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. Am J Obstet Gynecol (1993), 168:915–22.
30. , , , , and , A randomised double blind placebo controlled trial of fish oil in high risk pregnancy. BJOG (1995), 102:95–100.
31. , , , , , and , Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. BJOG (2000), 107:382–95.
32. , , , , , and , A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol (2003), 101:469–79.
33. , , , , and , Strategies to prevent and treat preeclampsia: evidence from randomized controlled trials. Semin Nephrol (2004), 24:607–15.
34. , , and , Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by preeclampsia or intrauterine growth restriction. Cochrane Database Syst Rev (2006), 3:CD003402.
35. , , , , , and , Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. Am J Obstet Gynecol (1998), 179:135–9.
36. , , and , Aged garlic extract and its constituents inhibit Cu(2+)-induced oxidative modification of low density lipoprotein. Plant Med (1997), 63:263–4.
37. , Antioxidant health effects of aged garlic extract. J Nutr (2001), 131:1010S–5S.
38. , Suppression of LDL oxidation by garlic. J Nutr (2001), 131:985S–8S.
39. , , and , Potent activation of nitric oxide synthase by garlic: a basis for its therapeutic applications. Curr Med Res Opin (1995), 13:257–63.
40. and , Garlic for preventing preeclampsia and its complications. Cochrane Database Syst Rev (2006b), 3:CD006065.
41. , , , and Lamyian M, The effect of garlic tablet on plasma lipids and platelet aggregation in nulliparous pregnants at high risk of preeclampsia. Eur J Obstet Gynecol Reprod Biol (2001), 99:201–6.
42. and , Ferritin, iron homeostasis, and oxidative damage. Free Radical Biol Med (2002), 33:457–63.
43. , , and , Free radicals, antioxidants, and nutrition. Nutrition (2002), 18:872–9.
44. , , , and , Increased levels of carboxyhemoglobin and serum iron as an indicator of increased red cell turnover in preeclampsia. Am J Obstet Gynecol (1987), 156:1169–73.
45. , , , , , and , The herbal medicine Tokishakuyakusan increases fetal blood glucose concentrations and growth hormone levels and improves intrauterine growth retardation induced by N(omega)-nitro-L-arginine methyl ester. J Pharmacol Sci (2007), 104:319–28.
46. , , , , , , and , Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet (2002), 359:1877–90.
47. and , Magnesium supplementation in pregnancy. Cochrane Database Syst Rev (2001), CD000937.
48. , , and , (1989) Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstet Gynecol, 161:115–9.
49. and , Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database Syst Rev (2006), 4:CD004905.
50. , The influence of dietary salt intake on pre-eclampsia. J Obstet Gynaecol Brit Commonw (1964), 71:123–5.
51. , , and , Altered dietary salt for preventing pre-eclampsia, and its complications. Cochrane Database Syst Rev (2005), 4:CD005548.
52. , , , and , Low sodium diet and pregnancy-induced hypertension: a multi-centre randomised controlled trial. BJOG (1998), 105:430–4.
53. , , , and , Dietary sodium restriction during pregnancy; a historical review. Eur J Obstet Gynecol Reprod Biol (1991), 40:83–90.
54. , , , and , Copper and zinc in pre-eclampsia. Acta Obstet Gynecol Scand (1984), 63:629–31.
55. , , , , , and , Maternal zinc, iron, folic acid, and protein nutriture and outcome of human pregnancy. Am J Clin Nutr (1984), 40:496–507.
56. , , , and , Potential contribution of maternal zinc supplementation during pregnancy to maternal and child survival. Am J Clin Nutr (1998), 68:499S–508S.
57. , , , and (1996) Zinc supplementation during pregnancy: a double blind randomised controlled trial. Acta Obstet Gynecol Scand 75:725–9.
58. , , , , , and . (1994) Bed rest in pregnancy. Obstet Gynecol 84:131–6.
59. , , and , Effective prevention of gestational hypertension in nulliparous women at high risk as identified by the rollover test. Am J Obstet Gynecol (1983), 146:166–8.
60. , Nutritional factors and rest reduce pregnancy-induced hypertension and preeclampsia in positive roll-over test primigravidas. Int J Gynaecol Obstet (1993), 41:31–5.
61. and , Rest during pregnancy for preventing preeclampsia and its complications in women with normal blood pressure. Cochrane Database Syste Rev (2006), 2:CD005939.
62. , , , and , The effect of maternal work on fetal growth and duration of pregnancy: a prospective study. BJOG (1990), 97:62–70.
63. , , and , Standing and walking at work and birthweight. Acta Obstet Gynecol Scand (1995), 74:509–16.
64. and , Exercise or other physical activity for preventing preeclampsia and its complications. Cochrane Database Syst Rev (2006), 2:CD005942.
65. , , , , , and , Effect of exercise on blood pressure in pregnant women with a high risk of gestational hypertensive disorders. J Reprod Med (2000), 45:293–8.
66. , , and , Preeclampsia and reproductive performance in a community of vegans. South Med J (1987), 80:692–7.
67. , , , , , , and , Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol (1995), 172:642–8.
68. , , , , , , et al., Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet and Gynecol (1997), 177:1003–10.
69. , , and , Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology (2003), 14:368–74.
70. , , , , , and , Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol (2001), 98:757–62.
71. , , , and , Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol (2005), 162:1198–206.
72. , , , and , The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol (2005), 15:475–82.